BioLargo Beheer
Beheer criteriumcontroles 4/4
BioLargo's CEO is Dennis Calvert, appointed in Jun 2002, has a tenure of 22.42 years. total yearly compensation is $316.59K, comprised of 91.2% salary and 8.8% bonuses, including company stock and options. directly owns 2.77% of the company’s shares, worth $1.83M. The average tenure of the management team and the board of directors is 19.2 years and 17.6 years respectively.
Belangrijke informatie
Dennis Calvert
Algemeen directeur
US$316.6k
Totale compensatie
| Percentage CEO-salaris | 91.2% |
| Dienstverband CEO | 22.4yrs |
| Eigendom CEO | 2.8% |
| Management gemiddelde ambtstermijn | 19.2yrs |
| Gemiddelde ambtstermijn bestuur | 17.6yrs |
Recente managementupdates
Recent updates
Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$3m |
| Mar 31 2024 | n/a | n/a | -US$4m |
| Dec 31 2023 | US$317k | US$289k | -US$4m |
| Sep 30 2023 | n/a | n/a | -US$4m |
| Jun 30 2023 | n/a | n/a | -US$3m |
| Mar 31 2023 | n/a | n/a | -US$3m |
| Dec 31 2022 | US$456k | US$289k | -US$4m |
| Sep 30 2022 | n/a | n/a | -US$6m |
| Jun 30 2022 | n/a | n/a | -US$7m |
| Mar 31 2022 | n/a | n/a | -US$7m |
| Dec 31 2021 | US$651k | US$289k | -US$7m |
| Sep 30 2021 | n/a | n/a | -US$6m |
| Jun 30 2021 | n/a | n/a | -US$7m |
| Mar 31 2021 | n/a | n/a | -US$8m |
| Dec 31 2020 | US$709k | US$289k | -US$8m |
| Sep 30 2020 | n/a | n/a | -US$9m |
| Jun 30 2020 | n/a | n/a | -US$11m |
| Mar 31 2020 | n/a | n/a | -US$10m |
| Dec 31 2019 | US$656k | US$289k | -US$11m |
| Sep 30 2019 | n/a | n/a | -US$10m |
| Jun 30 2019 | n/a | n/a | -US$9m |
| Mar 31 2019 | n/a | n/a | -US$10m |
| Dec 31 2018 | US$656k | US$289k | -US$10m |
| Sep 30 2018 | n/a | n/a | -US$10m |
| Jun 30 2018 | n/a | n/a | -US$10m |
| Mar 31 2018 | n/a | n/a | -US$9m |
| Dec 31 2017 | US$534k | US$289k | -US$9m |
Compensatie versus markt: Dennis's total compensation ($USD316.59K) is below average for companies of similar size in the US market ($USD655.65K).
Compensatie versus inkomsten: Dennis's compensation has been consistent with company performance over the past year.
CEO
Dennis Calvert (61 yo)
22.4yrs
Tenure
US$316,593
Compensatie
Mr. Dennis P. Calvert serves as the Chairman of the Board at BioLargo, Inc. and has been its Chief Executive Officer and President since June 28, 2002. Mr. Calvert has an extensive entrepreneurial backgrou...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chairman | 22.4yrs | US$316.59k | 2.77% $ 1.8m | |
| Chief Financial Officer | 16.8yrs | US$140.85k | 0.063% $ 41.7k | |
| Executive VP of Operations | 21.7yrs | US$258.65k | 0.56% $ 370.2k | |
| Chief Science Officer & Director | no data | US$301.20k | 0.97% $ 641.5k | |
| Director of Corporate Communications | 1.2yrs | geen gegevens | geen gegevens | |
| President of Clyra Medical Technologies Inc | no data | US$30.24k | geen gegevens | |
| President of BioLargo Engineering | no data | geen gegevens | geen gegevens | |
| President of BioLargo Canada | no data | geen gegevens | geen gegevens | |
| President of BioLargo Equipment Solutions & Technologies | no data | geen gegevens | geen gegevens |
19.2yrs
Gemiddelde duur
65yo
Gemiddelde leeftijd
Ervaren management: BLGO's management team is seasoned and experienced (19.2 years average tenure).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chairman | 22.4yrs | US$316.59k | 2.77% $ 1.8m | |
| Executive VP of Operations | 22.4yrs | US$258.65k | 0.56% $ 370.2k | |
| Chief Science Officer & Director | 17.6yrs | US$301.20k | 0.97% $ 641.5k | |
| Independent Director | 18.6yrs | US$154.83k | 0.086% $ 57.1k | |
| Independent Director | 7.4yrs | US$56.16k | 1.62% $ 1.1m | |
| Independent Director | 2yrs | US$70.20k | 0.063% $ 41.8k | |
| Independent Director | 2yrs | US$70.20k | 0% $ 0 |
17.6yrs
Gemiddelde duur
55yo
Gemiddelde leeftijd
Ervaren bestuur: BLGO's board of directors are seasoned and experienced ( 17.6 years average tenure).